NCT07049341View on ClinicalTrials.gov

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

NAEnrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Alzheimer's DiseaseFronto-temporal DementiaParkinson Disease (PD)Cortico Basal DegenerationPosterior Cortical Atrophy (PCA)Neurological Diseases or Conditions
Interventions
DEVICE

MemorEM

The MemorEM device delivers 915MHz electromagnetic waves to the head via 8 emitters in a cap worn on the head and powered by a control box and battery worn on the arm.

Trial Locations (1)

33602

NeuroEM Therapeutics, Tampa

Sponsors
All Listed Sponsors
lead

NeuroEM Therapeutics, Inc.

INDUSTRY

NCT07049341 - Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases | Biotech Hunter | Biotech Hunter